The Limited Times

Now you can see non-English news...

The booster dose of anti-Covid-19 vaccine authorized for 5-11 year olds in the United States

2022-05-17T16:50:24.694Z


Children aged 5 to 11 will in turn be able to receive a booster dose of Pfizer's anti-Covid vaccine, the...


Children aged 5 to 11 will in turn be able to receive a booster dose of Pfizer's anti-Covid vaccine, US health authorities announced on Tuesday May 17.

Read alsoCovid-19: vaccinating the most precarious, the lessons of a crisis

The US Medicines Agency (FDA) has authorized the booster dose for this age group "

to provide continued protection against Covid-19

", she explained in a press release.

A committee of experts from the Centers for Disease Control and Prevention (CDC) is due to meet Thursday to consider the issue in turn, and recommend this booster dose.

It must be injected at least 5 months after the first series of two injections.

The dosage used is 10 micrograms, both for the initial injections and for the booster dose (compared to 30 micrograms for ages 12 and older).

This authorization comes at a time when the United States is recording an increase in the number of Covid-19 cases, with around 90,000 us cases declared per day.

Hospitalizations are also on the rise.

5 to 11 years: 4.8 million cases

Covid-19 “

tends to be less severe in children than adults

,” FDA chief Robert Califf was quoted in the statement as saying.

But “

the wave linked to the Omicron variant has made more children sick and led to more hospitalizations and children suffering long-term effects

”, he underlined.

The United States has 28 million children between the ages of 5 and 11.

Among them, more than 4.8 million cases have been counted, and some 360 ​​deaths, according to CDC figures.

Read alsoCovid-19: child vaccination at an impasse

This age group has been eligible for vaccination with Pfizer since November 2021, but less than 30% of them are fully vaccinated.

The FDA again on Tuesday stressed the importance of vaccination to prevent serious cases of the disease.

Americans over 50 are already eligible for a second booster dose (fourth dose in all).

Children under 5 are not yet eligible for vaccination, with no vaccine, but a committee of independent experts is due to meet in June to review clinical trial data from Pfizer and Moderna for a authorization for this age group.

Source: lefigaro

All news articles on 2022-05-17

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.